Which medications in the drug class Immunomodulatory Agents are used in the treatment of Cutaneous Melanoma?

Updated: Oct 13, 2020
  • Author: Susan M Swetter, MD; Chief Editor: Dirk M Elston, MD  more...
  • Print

Immunomodulatory Agents

Immunomodulatory agents enhance host immunity for cancer surveillance and eradication.

Interferon alfa-2b (Intron A)

Interferon alfa-2b is a protein product manufactured by recombinant DNA technology. It is produced naturally by cells in the body to combat infections and tumors. Its mechanism of antitumor activity is not clearly understood; however, direct antiproliferative effects against malignant cells and modulation of host immune response may play important roles.

Interferon alfa-2b is generally initiated within 56 days of surgery and typically administered by medical oncologists.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!